Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Vitamin 25(OH)D3 deficiency was the most common in the study population, accounting for 66 patients (75.9%), while only 21 patients (24.1%) had higher levels.

Source: 3.1. Study Outcomes. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Full studies

Increased Retinol Levels in Patients with Cardiac Surgery-Associated Acute Kidney Injury: A Prospective Single-Center Exploratory Study

Study design awaiting verification · Nutrients · 2026

Original publication title

Increased Retinol Levels in Patients with Cardiac Surgery-Associated Acute Kidney Injury: A Prospective Single-Center Exploratory Study

Anna Olasińska-Wiśniewska; Ewelina Swora-Cwynar; Tomasz Urbanowicz; Marta Karaźniewicz-Łada; Julia Kerner; Anna Siemiątkowska; Agnieszka Dobrowolska; Bartłomiej Perek; Marek Jemielity

© 2026 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Retinol may be associated with increased vulnerability to cardiac surgery-associated AKI. However, its clinical utility as a biomarker requires validation in larger cohorts.

An extract from the source publication. Read it in context.

At a glance

Study background

What background does the paper provide?

Acute kidney injury (AKI) is a frequent complication of cardiac surgery and affects approximately 5% to 45% of patients [1]. It is associated with increased mortality, the need for temporary or permanent renal replacement therapy (RRT), prolonged intensive care unit stay, and longer hospitalization [2]. Even mild AKI may adversely affect short-term recovery. RRT is necessary in 1 to 5% of patients with postoperative AKI and is associated with worse prognosis in the short: and long-term follow-up [3].

Notably, even reversible postoperative kidney injury is also linked to an increased risk of chronic kidney disease (CKD) and long-term morbidity and mortality.

The pathophysiology of AKI is complex and multifactorial. Depending on baseline patient characteristics, surgical procedure, and perioperative complications, the severity of kidney injury may vary substantially. Several mechanisms are involved in the development of AKI, including inflammation, oxidative stress, hypoperfusion, ischemia: reperfusion injury, neurohormonal responses, labile iron-mediated toxicity, and exposure to nephrotoxic agents [3,4,5,6].

Numerous perioperative factors [7] have been identified as predictive for AKI (Supplementary Table S1). They may be classified as patient-related, such as age, female sex, pre-operative nutrition status; co-morbidities, including diabetes mellitus (DM), chronic obstructive pulmonary disease (COPD), peripheral arterial disease (PAD), heart failure (HF); procedural factors such as cardiopulmonary bypass (CPB) use, hemodilution, type of surgery; and postoperative such as low cardiac output and sepsis [3,8,9]. Cardiac surgery-associated AKI is linked to a higher incidence of other postoperative complications, including infection, prolonged intensive care unit stay, stroke, and heart failure [10].

Patients with preoperative impaired kidney function are at a particularly higher risk of adverse postoperative outcomes.

Chronic kidney disease (CKD) is characterized by exaggerated inflammatory response that contributes to increased morbidity and mortality. Inflammation is also implicated in the pathogenesis of coronary artery disease (CAD) and aortic stenosis (AS). Both types of heart diseases often co-exist with varying degrees of kidney dysfunction, reflecting their shared epidemiological and pathophysiological mechanisms, impaired peripheral blood flow, and a proinflammatory milieu [11]. Alterations in vitamin metabolism have recently emerged as an important issue in patients with CKD [12].

Vitamins E and A have anti-inflammatory and antiapoptotic effects, and vitamin D has been postulated to modulate inflammatory pathways [13,14,15,16]. Dysregulation of vitamin status has been associated with worse postoperative outcomes and higher complication rates [17].

The aim of the study was to determine whether preoperative levels of liposoluble vitamins differ in patients presenting with cardiac surgery-associated AKI and may be useful in the preoperative prediction of AKI.

Source: 1. Introduction Source: 1. Introduction Source: 1. Introduction Source: 1. Introduction Source: 1. Introduction

Study methods

What methods does the paper describe?

This prospective exploratory study included consecutive patients admitted to the cardiac surgery department between October 2024 and July 2025. The exclusion criteria were non-open-chest procedures, storage diseases, and isolated surgeries unrelated to CAD and/or AS. None of the patients followed a restrictive diet or used vitamin supplements systematically. Long-term vitamin supplementation was an exclusion criterion. Demographic and clinical data were collected at admission.

The inclusion of an age-matched healthy control group was not feasible, as such individuals would not undergo surgery, and therefore, the occurrence of cardiac surgery-associated AKI could not be assessed in this group.

Arterial hypertension (HA) was defined as systolic blood pressure of at least 140 mmHg and/or diastolic blood pressure of at least 90 mmHg, or use of antihypertensive medication. Diabetes mellitus (DM) and impaired glucose tolerance (IGT) were documented based on the medical history and medication use. Chronic obstructive pulmonary disease (COPD) was recorded according to the use of inhaled therapy. Smoking history was also obtained.

Preoperative echocardiography was performed using a standardized protocol. Valvular functions were assessed, including aortic stenosis severity based on peak and mean transvalvular gradients and aortic valve area, valvular insufficiencies, left ventricular contractility, left ventricular ejection fraction, and aortic root enlargement.

Coronary angiography was performed in all patients to assess the coronary atherosclerotic burden. Any history of percutaneous coronary angioplasty (PCI) was recorded.

Blood samples were collected for blood cell counts, serum creatinine, and N-terminal prohormone of brain natriuretic peptide (NT-proBNP).

Estimated glomerular filtration rate (eGFR) was calculated using the Modification of Diet in Renal Disease (MDRD) Study equation. Cardiac surgery-associated AKI [18] was defined according to Kidney Disease: Improving Global Outcomes (KDIGO) criteria, as an increase in serum creatinine (SCr) by at least 0.3 mg/dL within 48 h, an increase to at least 1.5 times baseline within 7 days, or urine output below 0.5 mL/kg/h for 6 h. Temporary kidney replacement therapy was recorded.

Blood samples for vitamin A, E, and D analysis were collected at patients’ admission to the hospital, after a 6 h fasting period, and centrifuged at 3000× g for 15 min at 4 °C. Serum was aliquoted and stored at −80 °C until analysis. We focused on fat-soluble vitamins because they are involved in several biological pathways relevant to the development of cardiac surgery-associated acute kidney injury, including oxidative stress, systemic inflammation, and endothelial dysfunction.

2.1. Analysis of Vitamins by UPLC-MS/MS Method

The analysis was carried out using a Shimadzu UPLC Nexera system coupled to an LCMS-8030 detector (Shimadzu Co., Kyoto, Japan). The separation of three analytes: vitamin A (retinol), vitamin E (α-tocopherol), and vitamin D (25-hydroxyvitamin D3, 25(OH)D3), along with their internal standards (ISs: retinol-C13, α-tocopherol-d6, 25-hydroxyvitamin D3-d6), was achieved on a Kinetex C18 column (100 × 2.1 mm; 2.6 μm) (Torrance, CA, USA). The column temperature was maintained at 40 °C. The mobile phase consisted of a methanol: water mixture, both containing 0.1% (v/v) formic acid, delivered using gradient elution at a flow rate of 0.45 mL/min.

The injection volume was set to 10 μL. Eluent was introduced into the MS interface using positive electrospray ionization (ESI+) mode. The electrospray capillary voltage was set at 4.5 kV. The MS interface parameters included a desolvation line temperature of 230 °C, a heat block temperature of 400 °C, and an interface temperature of 350 °C. Nitrogen was used as the drying gas and as the nebulizing gas with flow rates of 15 and 2 L/min, respectively. The multiple reaction monitoring (MRM) mode was used to monitor the specific transitions of the analytes.

The most sensitive mass transition was observed from m/z 269.2 to 93.0 for retinol, from m/z 431.3 to 165.1 for α-tocopherol, and from m/z 401.2 to 383.3 for 25-hydroxyvitamin D3. For their ISs, the following mass transitions were monitored: 272.2 ⟶ 84.0 for retinol-C13, 437.4 ⟶ 171.2 for α-tocopherol-d6, and 407.2 ⟶ 389.4 for 25-hydroxyvitamin D3-d6. Calibration curves of the analytes were prepared in concentration ranges of 0.02 to 2 mcg/mL for retinol, 0.5 to 20 mcg/mL for α-tocopherol and 5 to 125 ng/mL for 25-hydroxyvitamin D3.

The intra: and inter-day accuracy of the method, expressed as the relative error, was <15%. The intra: and inter-assay precision, expressed as the relative standard deviation, was <10%.

Patient samples were prepared by adding 20 μL of the ISs solution and 4 μL of 0.1% 2,6-di-tert-butyl-4-methylphenol (BHT) in methanol to 36 μL of patient serum. The mixture was vortexed for 10 s, followed by the addition of 90 μL of 0.1% BHT in methanol to induce protein precipitation, and vortexed again for 10 s. Subsequently, the samples were mixed for 5 min at 750 rpm and 4 °C, then centrifuged for 5 min at 18,000× g (4 °C).

The resulting supernatant was transferred to a clean glass vial and directly injected into the UPLC: MS/MS system. Patient samples for the analysis were prepared in duplicate, and two independent measurements were performed for each sample.

Reference values for vitamin concentrations are as follows: retinol, 0.3 to 0.7 mcg/mL; tocopherol, 5 to 20 mcg/mL; and vitamin D (25(OH)D3), 30 to 50 ng/mL.

2.2. Statistical Analysis

The Shapiro: Wilk test was applied to assess data distribution. Continuous variables were presented as medians (Q1: Q3) and were compared using the Mann: Whitney U tests for two groups or the Kruskal: Wallis for multiple subgroups. Categorical variables were expressed as frequencies (%) and were analyzed using the chi-squared test or Fisher’s exact test, as appropriate. Spearman’s rank correlation coefficient was used to evaluate the association between retinol levels and preoperative and postoperative kidney function parameters. Statistical analysis was performed using JASP software (JASP Team, 2025; The Netherlands, Amsterdam, Version 0.19.3) and p < 0.05 was considered statistically significant.

The project was approved by the Bioethics committee of the Poznan University of Medical Sciences, Poznan, Poland (No 272/2021 dated 8 April 2021 and No 151/25 dated 3 April 2025). This study was performed in line with the principles of the Declaration of Helsinki. Informed consent was obtained from all individual participants included in the study.

Source: 2. Materials and Methods Source: 2. Materials and Methods Source: 2. Materials and Methods Source: 2. Materials and Methods Source: 2. Materials and Methods Source: 2. Materials and Methods Source: 2. Materials and Methods Source: 2. Materials and Methods Source: 2. Materials and Methods Source: 2. Materials and Methods

Results: Study Outcomes

The analysis included 96 patients who were admitted for cardiac surgery (Figure 1). Nine patients met the exclusion criteria: three did not undergo open-chest cardiac surgery, one had a storage disease, and five underwent procedures other than coronary artery bypass grafting (CABG) and/or aortic valve replacement (AVR). The final study group comprised 87 patients, including 72 males (82.8%), with a median (Q1: Q3) age of 66 (61.5 to 71) years. Sixty-five patients were operated on due to severe CAD, 18 due to severe AS, and four underwent a combined CABG + AVR.

The majority of patients presented with cardiovascular risk factors, including arterial hypertension (n = 73, 83.9%), diabetes mellitus or IGT (n = 32, 36.8%), COPD or asthma requiring inhaled medication (n = 7, 8%), and a history or cardiovascular disease, including previous myocardial infarction (n = 18, 20.7%), previous PCI (n = 12, 13.8%), stroke or transient ischemic attack (TIA) (n = 6, 6.9%), and peripheral artery disease (PAD) (n = 14, 16.1%).

In addition, 14 patients (16.1%) had preoperative eGFR below 60 mL/min. Baseline demographic and clinical characteristics are summarized in Table 1.

Postoperative AKI, defined as an increase in serum creatinine of more than 0.3 mg/dL within 48 h, or to more than 1.5 times baseline, occurred in 36 patients (41.4%). In 34 of these patients, AKI was mild and transient, whereas 2 required temporary RRT. No patient required permanent RRT.

Vitamin 25(OH)D3 deficiency was the most common in the study population, accounting for 66 patients (75.9%), while only 21 patients (24.1%) had higher levels. Retinol deficiency was observed in 2 patients; the majority (60.9%, n = 53) had values within the normal range, and 36.8% (n = 32) had values above the normal range. Tocopherol levels were within normal values in 88.5% (n = 77), while 10 patients (11.5%) showed levels that were excessive.

Vitamin concentrations were statistically significantly higher in the AKI subgroup; however, only retinol levels differed significantly between subgroups (p = 0.046) (Table 1). Retinol concentrations correlated positively with preoperative creatinine (Spearman’s rho 0.321, p = 0.002), postoperative day 0 creatinine (Spearman’s rho 0.333, p = 0.002), and postoperative day 1 creatinine (Spearman’s rho 0.268, p = 0.012), and negatively with preoperative eGFR (Spearman’s rho −0.288, p = 0.007). The association with postoperative day 2 creatinine did not reach statistical significance (Spearman’s rho 0.209, p = 0.053) (Figure 2).

Two patients who required temporary RRT had the highest retinol levels compared to those with AKI who did not require RRT and with patients without AKI (p = 0.026, 1.22 (1.05 to 1.38) mcg/mL vs. 0.63 (0.54 to 0.77) mcg/mL vs. 0.56 (0.45 to 0.72) mcg/mL).

Table 1

Baseline demographic and clinical characteristics.

All Patients
(n = 87)
Patients with AKI (n = 36)Patients Without AKI (n = 51) p
Age66 (61.5 to 71)68.5 (64 to 73)66 (60 to 70)0.025
Male sex (n, %)72 (82.8)29 (80.6)43 (84.3)0.78
BMI (kg/m2, median, Q1: Q3)28.4 (25.6 to 31.4)28.6 (26.2 to 31.1)28.3 (24.9 to 32.2)0.73
HA (n, %)73 (83.9)31 (86.1)42 (82.4)0.77
DM/IGT (n, %)32 (36.8)16 (44.4)16 (31.4)0.21
Only DM (n, %)28 (32.2)15 (41.7)13 (25.5)0.11
AF (n, %)10 (11.5)4 (11.1)6 (11.8)1.00
COPD/asthma (n, %)7 (8.1)2 (5.6)5 (9.8)0.70
History of MI (n, %)18 (20.9)6 (16.7)12 (24)0.59
History of PCI (n, %)12 (14.0)5 (13.9)7 (14)1.00
Previous stroke or TIA (n, %)36 (6.0)2 (5.6)4 (8.0)1.00
PAD (n, %)14 (16.3)8 (22.2)6 (12.0)0.24
CPB (n, %)25 (28.7)8 (22.2)17 (33.3)0.34
Preoperative creatinine (umol/L, median, Q1: Q3)0.90 (0.76 to 1.02)0.95 (0.82 to 1.15)0.87 (0.73 to 0.98)0.01
Preoperative eGFR (mL/min, median, Q1: Q3)85.2 (68.1 to 99.1)68.5 (59.3 to 89.4)87.8 (74.4 to 103.2)0.002
Preoperative eGFR < 60 mL/min (n, %)14 (16.1)11 (30.6)3 (5.9)0.002
Preoperative leucocyte count (×109/L, median, Q1: Q3)7.4 (6 to 8.6)7.5 (6.3 to 8.3)7.1 (5.8 to 8.8)0.97
Preoperative haemoglobin (mmol/L, median, Q1: Q3)8.6 (8.2 to 9.3)8.4 (8.1 to 9.1)8.8 (8.4 to 9.5)0.035
Preoperative erythrocyte count (×1012/L, median, Q1: Q3)4.7 (4.4 to 5.0)4.6 (4.3 to 4.8)4.8 (4.5 to 5.1)0.04
Preoperative platelet count (×109/L, median, Q1: Q3)230 (193 to 269)228 (188 to 253)230 (197 to 292)0.26
Preoperative NTproBNP (pg/mL, median, Q1: Q3)427.7 (184.1 to 570.1)462.6 (435.5 to 605.9)186.9 (106.9 to 432.3)0.19
ALT (U/L, median, Q1: Q3)33.0 (21.0 to 44.3)33.5 (23.3 to 41.3)32.0 (21.0 to 47.3)0.84
AST (U/L, median, Q1: Q3)27.0 (22.8 to 37.0)28.0 (24.3 to 40.5027 (22.0 to 34.8)0.41
Postoperative 0 day
Creatinine (umol/L, median, Q1: Q3)
1.04 (0.92 to 1.22)1.23 (1.03 to 1.42)0.93 (0.84 to 1.07)<0.001
Postoperative 1 day
Creatinine (umol/L, median, Q1: Q3)
1.12 (0.88 to 1.39)1.43 (1.22 to 1.75)0.93 (0.80 to 1.11)<0.001
Postoperative 2 day
Creatinine (umol/L, median, Q1: Q3)
0.98 (0.78 to 1.27)1.26 (1.09 to 1.59)0.84 (0.68 to 1.00)<0.001
Retinol (mcg/mL, median, Q1: Q3)0.59 (0.48 to 0.75)0.64 (0.56 to 0.83)0.56 (0.45 to 0.72)0.046
25(OH)D3 (ng/mL, median, Q1: Q3)14.4 (6.1 to 27.2)15.0 (7.6 to 28.2)10.2 (5.7 to 25.2)0.37
Tocopherol (mcg/mL, median, Q1: Q3)12.7 (9.7 to 16.5)13.4 (9.6 to 16.9)12.5 (9.9 to 15.7)0.33

Abbreviations: AKI: acute kidney injury; AF: atrial fibrillation; ALT: alanine aminotransferase; AST: aspartate aminotransferase; BMI: body mass index; COPD: chronic obstructive pulmonary disease; CPB: cardiopulmonary bypass; DM: diabetes mellitus; eGFR: estimated glomerular filtration rate; IGT: impaired glucose tolerance; HA: arterial hypertension; MI: myocardial infarction; NTproBNP: N-terminal pro-B-type natriuretic peptide; PAD: peripheral arterial disease; PCI: percutaneous coronary intervention; TIA: transient ischemic attack.

Source: 3.1. Study Outcomes Source: 3.1. Study Outcomes Source: 3.1. Study Outcomes Source: 3.1. Study Outcomes Source: 3.1. Study Outcomes Source: 3.1. Study Outcomes Source: 3.1. Study Outcomes

Subdivision into Diabetic and Non-Diabetic Patients

Results: Subdivision into Diabetic and Non-Diabetic Patients

Given that several studies have highlighted the association between diabetic nephropathy and alterations in vitamin concentrations, we analyzed vitamin status in the relevant subgroups. We did not reveal differences between subgroups with and without DM, with or without AKI (Table 2).

Table 2

Vitamin levels in patients with and without DM, presenting with or without AKI.

DM(+)AKI(+)DM(+)AKI(−)DM(−)AKI(+)DM(−)AKI(−) p
Retinol (mcg/mL, median, Q1: Q3)0.69 (0.57 to 0.87)0.56 (0.46 to 0.76)0.63 (0.54 to 0.73)0.56 (0.45 to 0.71)0.20
25(OH)D3 (ng/mL, median, Q1: Q3)14.7 (5.6 to 24.0)9.9 (6.2 to 18.1)17.0 (9.0 to 31.1)11.5 (5.6 to 32.3)0.41
Tocopherol (mcg/mL, median, Q1: Q3)12.8 (9.4 to 16.8)13.9 (13.0 to 17.8)13.9 (11.1 to 16.9)11.3 (9.6 to 15.0)0.23

Abbreviations: AKI: acute kidney injury; DM: diabetes mellitus. (+) presence; (−) absence.

Source: 3.2. Subdivision into Diabetic and Non-Diabetic Patients Source: 3.2. Subdivision into Diabetic and Non-Diabetic Patients

Results: Sex-Stratified Analysis

Male dominance was observed in our study population. Therefore, we performed a sex-stratified analysis to assess whether sex could account for the variance in vitamin concentrations.

In linear regression analysis, sex was significantly associated with preoperative 25(OH)D3 concentrations (unstandardized β = −12.1, (95% CI: −21.4: −2.9), p = 0.011), indicating lower vitamin D in women than in men. Sex alone explained approximately 7% of the variance in 25(OH)D3 concentrations (R2 = 0.074, adjusted R2 = 0.063). Sex was not significantly associated with serum retinol concentrations (unstandardized β = 0.02, 95% CI −0.11 to 0.14, p = 0.759) and had an almost negligible impact on the variance in its concentration (R2 = 0.001, adjusted R2 = −0.011).

Tocopherol concentration was not significantly associated with sex (unstandardized β = −3.0 mcg/mL, 95% CI −6.3 to 0.3, p = 0.077), with sex accounting for only a small proportion of the variance in its concentration (R2 = 0.036, adjusted R2 = 0.025).

Source: 3.3. Sex-Stratified Analysis Source: 3.3. Sex-Stratified Analysis

Discussion: Future Perspective

In the context of the emerging “twin transformation” in cardiothoracic surgery, which combines digital innovation with sustainability-oriented care models [59], improved risk stratification for cardiac surgery-associated AKI using clinical variables and biomarkers may contribute to more precise and clinically efficient perioperative pathways. A recent study by Pylarinou et al. [60] introduced a clinical decision support system specifically designed for post-surgical cardiovascular remote monitoring, integrating patient history, intraoperative data, monitoring streams, and surgical outcomes into an artificial intelligence-based architecture that may guide clinical recommendations.

The implementation of artificial intelligence-assisted decision-making tools, the earlier identification of patients at higher risk of post-operative complications, including even a mild degree of AKI, and targeted modifications to improve outcomes by reducing the complication rate, the need for RRT, and prolonged intensive care stay.

Source: 4.1. Future Perspective

Study limitations

Discussion: What limitations does the paper describe?

This study has several limitations. Firstly, in our study, serum or urine RBP4 was not measured, which limited the assessment of vitamin A transport and metabolism. Secondly, the study population was burdened by several comorbidities, which may limit generalizability. Finally, given that the patient group was relatively small, particularly with respect to severe AKI and RRT use, and the borderline statistical significance for retinol (p = 0.046), and the exploratory nature of the study, the present finding should be treated as hypothesis-generating.

Source: 4.2. Limitations

Results

3.1. Study Outcomes

The analysis included 96 patients who were admitted for cardiac surgery (Figure 1). Nine patients met the exclusion criteria: three did not undergo open-chest cardiac surgery, one had a storage disease, and five underwent procedures other than coronary artery bypass grafting (CABG) and/or aortic valve replacement (AVR). The final study group comprised 87 patients, including 72 males (82.8%), with a median (Q1: Q3) age of 66 (61.5 to 71) years. Sixty-five patients were operated on due to severe CAD, 18 due to severe AS, and four underwent a combined CABG + AVR.

The majority of patients presented with cardiovascular risk factors, including arterial hypertension (n = 73, 83.9%), diabetes mellitus or IGT (n = 32, 36.8%), COPD or asthma requiring inhaled medication (n = 7, 8%), and a history or cardiovascular disease, including previous myocardial infarction (n = 18, 20.7%), previous PCI (n = 12, 13.8%), stroke or transient ischemic attack (TIA) (n = 6, 6.9%), and peripheral artery disease (PAD) (n = 14, 16.1%).

In addition, 14 patients (16.1%) had preoperative eGFR below 60 mL/min. Baseline demographic and clinical characteristics are summarized in Table 1.

Postoperative AKI, defined as an increase in serum creatinine of more than 0.3 mg/dL within 48 h, or to more than 1.5 times baseline, occurred in 36 patients (41.4%). In 34 of these patients, AKI was mild and transient, whereas 2 required temporary RRT. No patient required permanent RRT.

Vitamin 25(OH)D3 deficiency was the most common in the study population, accounting for 66 patients (75.9%), while only 21 patients (24.1%) had higher levels. Retinol deficiency was observed in 2 patients; the majority (60.9%, n = 53) had values within the normal range, and 36.8% (n = 32) had values above the normal range. Tocopherol levels were within normal values in 88.5% (n = 77), while 10 patients (11.5%) showed levels that were excessive.

Vitamin concentrations were statistically significantly higher in the AKI subgroup; however, only retinol levels differed significantly between subgroups (p = 0.046) (Table 1). Retinol concentrations correlated positively with preoperative creatinine (Spearman’s rho 0.321, p = 0.002), postoperative day 0 creatinine (Spearman’s rho 0.333, p = 0.002), and postoperative day 1 creatinine (Spearman’s rho 0.268, p = 0.012), and negatively with preoperative eGFR (Spearman’s rho −0.288, p = 0.007). The association with postoperative day 2 creatinine did not reach statistical significance (Spearman’s rho 0.209, p = 0.053) (Figure 2).

Two patients who required temporary RRT had the highest retinol levels compared to those with AKI who did not require RRT and with patients without AKI (p = 0.026, 1.22 (1.05 to 1.38) mcg/mL vs. 0.63 (0.54 to 0.77) mcg/mL vs. 0.56 (0.45 to 0.72) mcg/mL).

3.2. Subdivision into Diabetic and Non-Diabetic Patients

Given that several studies have highlighted the association between diabetic nephropathy and alterations in vitamin concentrations, we analyzed vitamin status in the relevant subgroups. We did not reveal differences between subgroups with and without DM, with or without AKI (Table 2).

3.3. Sex-Stratified Analysis

Male dominance was observed in our study population. Therefore, we performed a sex-stratified analysis to assess whether sex could account for the variance in vitamin concentrations.

In linear regression analysis, sex was significantly associated with preoperative 25(OH)D3 concentrations (unstandardized β = −12.1, (95% CI: −21.4: −2.9), p = 0.011), indicating lower vitamin D in women than in men. Sex alone explained approximately 7% of the variance in 25(OH)D3 concentrations (R2 = 0.074, adjusted R2 = 0.063). Sex was not significantly associated with serum retinol concentrations (unstandardized β = 0.02, 95% CI −0.11 to 0.14, p = 0.759) and had an almost negligible impact on the variance in its concentration (R2 = 0.001, adjusted R2 = −0.011).

Tocopherol concentration was not significantly associated with sex (unstandardized β = −3.0 mcg/mL, 95% CI −6.3 to 0.3, p = 0.077), with sex accounting for only a small proportion of the variance in its concentration (R2 = 0.036, adjusted R2 = 0.025).

Table 1

Baseline demographic and clinical characteristics.

All Patients
(n = 87)
Patients with AKI (n = 36)Patients Without AKI (n = 51) p
Age66 (61.5 to 71)68.5 (64 to 73)66 (60 to 70)0.025
Male sex (n, %)72 (82.8)29 (80.6)43 (84.3)0.78
BMI (kg/m2, median, Q1: Q3)28.4 (25.6 to 31.4)28.6 (26.2 to 31.1)28.3 (24.9 to 32.2)0.73
HA (n, %)73 (83.9)31 (86.1)42 (82.4)0.77
DM/IGT (n, %)32 (36.8)16 (44.4)16 (31.4)0.21
Only DM (n, %)28 (32.2)15 (41.7)13 (25.5)0.11
AF (n, %)10 (11.5)4 (11.1)6 (11.8)1.00
COPD/asthma (n, %)7 (8.1)2 (5.6)5 (9.8)0.70
History of MI (n, %)18 (20.9)6 (16.7)12 (24)0.59
History of PCI (n, %)12 (14.0)5 (13.9)7 (14)1.00
Previous stroke or TIA (n, %)36 (6.0)2 (5.6)4 (8.0)1.00
PAD (n, %)14 (16.3)8 (22.2)6 (12.0)0.24
CPB (n, %)25 (28.7)8 (22.2)17 (33.3)0.34
Preoperative creatinine (umol/L, median, Q1: Q3)0.90 (0.76 to 1.02)0.95 (0.82 to 1.15)0.87 (0.73 to 0.98)0.01
Preoperative eGFR (mL/min, median, Q1: Q3)85.2 (68.1 to 99.1)68.5 (59.3 to 89.4)87.8 (74.4 to 103.2)0.002
Preoperative eGFR < 60 mL/min (n, %)14 (16.1)11 (30.6)3 (5.9)0.002
Preoperative leucocyte count (×109/L, median, Q1: Q3)7.4 (6 to 8.6)7.5 (6.3 to 8.3)7.1 (5.8 to 8.8)0.97
Preoperative haemoglobin (mmol/L, median, Q1: Q3)8.6 (8.2 to 9.3)8.4 (8.1 to 9.1)8.8 (8.4 to 9.5)0.035
Preoperative erythrocyte count (×1012/L, median, Q1: Q3)4.7 (4.4 to 5.0)4.6 (4.3 to 4.8)4.8 (4.5 to 5.1)0.04
Preoperative platelet count (×109/L, median, Q1: Q3)230 (193 to 269)228 (188 to 253)230 (197 to 292)0.26
Preoperative NTproBNP (pg/mL, median, Q1: Q3)427.7 (184.1 to 570.1)462.6 (435.5 to 605.9)186.9 (106.9 to 432.3)0.19
ALT (U/L, median, Q1: Q3)33.0 (21.0 to 44.3)33.5 (23.3 to 41.3)32.0 (21.0 to 47.3)0.84
AST (U/L, median, Q1: Q3)27.0 (22.8 to 37.0)28.0 (24.3 to 40.5027 (22.0 to 34.8)0.41
Postoperative 0 day
Creatinine (umol/L, median, Q1: Q3)
1.04 (0.92 to 1.22)1.23 (1.03 to 1.42)0.93 (0.84 to 1.07)<0.001
Postoperative 1 day
Creatinine (umol/L, median, Q1: Q3)
1.12 (0.88 to 1.39)1.43 (1.22 to 1.75)0.93 (0.80 to 1.11)<0.001
Postoperative 2 day
Creatinine (umol/L, median, Q1: Q3)
0.98 (0.78 to 1.27)1.26 (1.09 to 1.59)0.84 (0.68 to 1.00)<0.001
Retinol (mcg/mL, median, Q1: Q3)0.59 (0.48 to 0.75)0.64 (0.56 to 0.83)0.56 (0.45 to 0.72)0.046
25(OH)D3 (ng/mL, median, Q1: Q3)14.4 (6.1 to 27.2)15.0 (7.6 to 28.2)10.2 (5.7 to 25.2)0.37
Tocopherol (mcg/mL, median, Q1: Q3)12.7 (9.7 to 16.5)13.4 (9.6 to 16.9)12.5 (9.9 to 15.7)0.33

Abbreviations: AKI: acute kidney injury; AF: atrial fibrillation; ALT: alanine aminotransferase; AST: aspartate aminotransferase; BMI: body mass index; COPD: chronic obstructive pulmonary disease; CPB: cardiopulmonary bypass; DM: diabetes mellitus; eGFR: estimated glomerular filtration rate; IGT: impaired glucose tolerance; HA: arterial hypertension; MI: myocardial infarction; NTproBNP: N-terminal pro-B-type natriuretic peptide; PAD: peripheral arterial disease; PCI: percutaneous coronary intervention; TIA: transient ischemic attack.

Table 2

Vitamin levels in patients with and without DM, presenting with or without AKI.

DM(+)AKI(+)DM(+)AKI(−)DM(−)AKI(+)DM(−)AKI(−) p
Retinol (mcg/mL, median, Q1: Q3)0.69 (0.57 to 0.87)0.56 (0.46 to 0.76)0.63 (0.54 to 0.73)0.56 (0.45 to 0.71)0.20
25(OH)D3 (ng/mL, median, Q1: Q3)14.7 (5.6 to 24.0)9.9 (6.2 to 18.1)17.0 (9.0 to 31.1)11.5 (5.6 to 32.3)0.41
Tocopherol (mcg/mL, median, Q1: Q3)12.8 (9.4 to 16.8)13.9 (13.0 to 17.8)13.9 (11.1 to 16.9)11.3 (9.6 to 15.0)0.23

Abbreviations: AKI: acute kidney injury; DM: diabetes mellitus. (+) presence; (−) absence.

Source: 3. Results Source: 3. Results Source: 3. Results Source: 3. Results Source: 3. Results

Conclusions

Retinol may be associated with increased vulnerability to cardiac surgery-associated AKI. However, its clinical utility as a biomarker requires validation in larger cohorts.

Source: 5. Conclusions
Authors’ abstract

Background: Acute kidney injury (AKI) is a frequent and prognostically important complication of cardiac surgery, yet early risk stratification remains challenging. The purpose of this prospective exploratory study was to determine whether preoperative vitamin levels differ in patients who develop cardiac surgery-associated AKI. Methods: Consecutive patients scheduled for cardiac surgery due to coronary artery disease and/or severe aortic stenosis between October 2024 and July 2025 were included. Fourteen patients (16.1%) had preoperative eGFR below 60 mL/min. Preoperative serum levels of vitamin A (retinol), vitamin E (α-tocopherol), and vitamin D (25-hydroxyvitamin D3) were measured.

Results: A total of 87 patients (72 males (82.8%) with a median (Q1: Q3) age of 66 (61.5 to 71) years) were included in the study. Cardiac surgery-associated AKI occurred in 36 (41.4%), as a mild and transient impairment, with only two patients with a more severe stage requiring temporary renal replacement therapy. Patients who developed AKI had significantly higher preoperative retinol levels (p = 0.046). Retinol concentrations correlated positively with preoperative creatinine (Spearman’s rho 0.321, p = 0.002), postoperative day 0 creatinine (Spearman’s rho 0.333, p = 0.002), and postoperative day 1 creatinine (Spearman’s rho 0.268, p = 0.012), and negatively with preoperative eGFR (Spearman’s rho −0.288, p = 0.007).

Tocopherol and 25(OH)D3 did not differ significantly between subgroups. No difference in vitamin levels was observed between patients with and without diabetes. Conclusions: Increased preoperative retinol levels were associated with cardiac surgery-associated AKI and correlated with perioperative renal dysfunction. Retinol may reflect impaired kidney handling of retinol and identify increased renal vulnerability in cardiac surgery patients. Retinol may represent a hypothesis-generating biomarker of cardiac surgery-associated AKI risk that warrants confirmation in larger cohorts.

Read the full paper

1. Introduction

Acute kidney injury (AKI) is a frequent complication of cardiac surgery and affects approximately 5% to 45% of patients [1]. It is associated with increased mortality, the need for temporary or permanent renal replacement therapy (RRT), prolonged intensive care unit stay, and longer hospitalization [2]. Even mild AKI may adversely affect short-term recovery. RRT is necessary in 1 to 5% of patients with postoperative AKI and is associated with worse prognosis in the short: and long-term follow-up [3].

Notably, even reversible postoperative kidney injury is also linked to an increased risk of chronic kidney disease (CKD) and long-term morbidity and mortality.

The pathophysiology of AKI is complex and multifactorial. Depending on baseline patient characteristics, surgical procedure, and perioperative complications, the severity of kidney injury may vary substantially. Several mechanisms are involved in the development of AKI, including inflammation, oxidative stress, hypoperfusion, ischemia: reperfusion injury, neurohormonal responses, labile iron-mediated toxicity, and exposure to nephrotoxic agents [3,4,5,6].

Numerous perioperative factors [7] have been identified as predictive for AKI (Supplementary Table S1). They may be classified as patient-related, such as age, female sex, pre-operative nutrition status; co-morbidities, including diabetes mellitus (DM), chronic obstructive pulmonary disease (COPD), peripheral arterial disease (PAD), heart failure (HF); procedural factors such as cardiopulmonary bypass (CPB) use, hemodilution, type of surgery; and postoperative such as low cardiac output and sepsis [3,8,9]. Cardiac surgery-associated AKI is linked to a higher incidence of other postoperative complications, including infection, prolonged intensive care unit stay, stroke, and heart failure [10].

Patients with preoperative impaired kidney function are at a particularly higher risk of adverse postoperative outcomes.

Chronic kidney disease (CKD) is characterized by exaggerated inflammatory response that contributes to increased morbidity and mortality. Inflammation is also implicated in the pathogenesis of coronary artery disease (CAD) and aortic stenosis (AS). Both types of heart diseases often co-exist with varying degrees of kidney dysfunction, reflecting their shared epidemiological and pathophysiological mechanisms, impaired peripheral blood flow, and a proinflammatory milieu [11]. Alterations in vitamin metabolism have recently emerged as an important issue in patients with CKD [12].

Vitamins E and A have anti-inflammatory and antiapoptotic effects, and vitamin D has been postulated to modulate inflammatory pathways [13,14,15,16]. Dysregulation of vitamin status has been associated with worse postoperative outcomes and higher complication rates [17].

The aim of the study was to determine whether preoperative levels of liposoluble vitamins differ in patients presenting with cardiac surgery-associated AKI and may be useful in the preoperative prediction of AKI.

2. Materials and Methods

This prospective exploratory study included consecutive patients admitted to the cardiac surgery department between October 2024 and July 2025. The exclusion criteria were non-open-chest procedures, storage diseases, and isolated surgeries unrelated to CAD and/or AS. None of the patients followed a restrictive diet or used vitamin supplements systematically. Long-term vitamin supplementation was an exclusion criterion. Demographic and clinical data were collected at admission.

The inclusion of an age-matched healthy control group was not feasible, as such individuals would not undergo surgery, and therefore, the occurrence of cardiac surgery-associated AKI could not be assessed in this group.

Arterial hypertension (HA) was defined as systolic blood pressure of at least 140 mmHg and/or diastolic blood pressure of at least 90 mmHg, or use of antihypertensive medication. Diabetes mellitus (DM) and impaired glucose tolerance (IGT) were documented based on the medical history and medication use. Chronic obstructive pulmonary disease (COPD) was recorded according to the use of inhaled therapy. Smoking history was also obtained.

Preoperative echocardiography was performed using a standardized protocol. Valvular functions were assessed, including aortic stenosis severity based on peak and mean transvalvular gradients and aortic valve area, valvular insufficiencies, left ventricular contractility, left ventricular ejection fraction, and aortic root enlargement.

Coronary angiography was performed in all patients to assess the coronary atherosclerotic burden. Any history of percutaneous coronary angioplasty (PCI) was recorded.

Blood samples were collected for blood cell counts, serum creatinine, and N-terminal prohormone of brain natriuretic peptide (NT-proBNP).

Estimated glomerular filtration rate (eGFR) was calculated using the Modification of Diet in Renal Disease (MDRD) Study equation. Cardiac surgery-associated AKI [18] was defined according to Kidney Disease: Improving Global Outcomes (KDIGO) criteria, as an increase in serum creatinine (SCr) by at least 0.3 mg/dL within 48 h, an increase to at least 1.5 times baseline within 7 days, or urine output below 0.5 mL/kg/h for 6 h. Temporary kidney replacement therapy was recorded.

Blood samples for vitamin A, E, and D analysis were collected at patients’ admission to the hospital, after a 6 h fasting period, and centrifuged at 3000× g for 15 min at 4 °C. Serum was aliquoted and stored at −80 °C until analysis. We focused on fat-soluble vitamins because they are involved in several biological pathways relevant to the development of cardiac surgery-associated acute kidney injury, including oxidative stress, systemic inflammation, and endothelial dysfunction.

2.1. Analysis of Vitamins by UPLC-MS/MS Method

The analysis was carried out using a Shimadzu UPLC Nexera system coupled to an LCMS-8030 detector (Shimadzu Co., Kyoto, Japan). The separation of three analytes: vitamin A (retinol), vitamin E (α-tocopherol), and vitamin D (25-hydroxyvitamin D3, 25(OH)D3), along with their internal standards (ISs: retinol-C13, α-tocopherol-d6, 25-hydroxyvitamin D3-d6), was achieved on a Kinetex C18 column (100 × 2.1 mm; 2.6 μm) (Torrance, CA, USA). The column temperature was maintained at 40 °C. The mobile phase consisted of a methanol: water mixture, both containing 0.1% (v/v) formic acid, delivered using gradient elution at a flow rate of 0.45 mL/min.

The injection volume was set to 10 μL. Eluent was introduced into the MS interface using positive electrospray ionization (ESI+) mode. The electrospray capillary voltage was set at 4.5 kV. The MS interface parameters included a desolvation line temperature of 230 °C, a heat block temperature of 400 °C, and an interface temperature of 350 °C. Nitrogen was used as the drying gas and as the nebulizing gas with flow rates of 15 and 2 L/min, respectively. The multiple reaction monitoring (MRM) mode was used to monitor the specific transitions of the analytes.

The most sensitive mass transition was observed from m/z 269.2 to 93.0 for retinol, from m/z 431.3 to 165.1 for α-tocopherol, and from m/z 401.2 to 383.3 for 25-hydroxyvitamin D3. For their ISs, the following mass transitions were monitored: 272.2 ⟶ 84.0 for retinol-C13, 437.4 ⟶ 171.2 for α-tocopherol-d6, and 407.2 ⟶ 389.4 for 25-hydroxyvitamin D3-d6. Calibration curves of the analytes were prepared in concentration ranges of 0.02 to 2 mcg/mL for retinol, 0.5 to 20 mcg/mL for α-tocopherol and 5 to 125 ng/mL for 25-hydroxyvitamin D3.

The intra: and inter-day accuracy of the method, expressed as the relative error, was <15%. The intra: and inter-assay precision, expressed as the relative standard deviation, was <10%.

Patient samples were prepared by adding 20 μL of the ISs solution and 4 μL of 0.1% 2,6-di-tert-butyl-4-methylphenol (BHT) in methanol to 36 μL of patient serum. The mixture was vortexed for 10 s, followed by the addition of 90 μL of 0.1% BHT in methanol to induce protein precipitation, and vortexed again for 10 s. Subsequently, the samples were mixed for 5 min at 750 rpm and 4 °C, then centrifuged for 5 min at 18,000× g (4 °C).

The resulting supernatant was transferred to a clean glass vial and directly injected into the UPLC: MS/MS system. Patient samples for the analysis were prepared in duplicate, and two independent measurements were performed for each sample.

Reference values for vitamin concentrations are as follows: retinol, 0.3 to 0.7 mcg/mL; tocopherol, 5 to 20 mcg/mL; and vitamin D (25(OH)D3), 30 to 50 ng/mL.

2.2. Statistical Analysis

The Shapiro: Wilk test was applied to assess data distribution. Continuous variables were presented as medians (Q1: Q3) and were compared using the Mann: Whitney U tests for two groups or the Kruskal: Wallis for multiple subgroups. Categorical variables were expressed as frequencies (%) and were analyzed using the chi-squared test or Fisher’s exact test, as appropriate. Spearman’s rank correlation coefficient was used to evaluate the association between retinol levels and preoperative and postoperative kidney function parameters. Statistical analysis was performed using JASP software (JASP Team, 2025; The Netherlands, Amsterdam, Version 0.19.3) and p < 0.05 was considered statistically significant.

The project was approved by the Bioethics committee of the Poznan University of Medical Sciences, Poznan, Poland (No 272/2021 dated 8 April 2021 and No 151/25 dated 3 April 2025). This study was performed in line with the principles of the Declaration of Helsinki. Informed consent was obtained from all individual participants included in the study.

3. Results

3.1. Study Outcomes

The analysis included 96 patients who were admitted for cardiac surgery (Figure 1). Nine patients met the exclusion criteria: three did not undergo open-chest cardiac surgery, one had a storage disease, and five underwent procedures other than coronary artery bypass grafting (CABG) and/or aortic valve replacement (AVR). The final study group comprised 87 patients, including 72 males (82.8%), with a median (Q1: Q3) age of 66 (61.5 to 71) years. Sixty-five patients were operated on due to severe CAD, 18 due to severe AS, and four underwent a combined CABG + AVR.

The majority of patients presented with cardiovascular risk factors, including arterial hypertension (n = 73, 83.9%), diabetes mellitus or IGT (n = 32, 36.8%), COPD or asthma requiring inhaled medication (n = 7, 8%), and a history or cardiovascular disease, including previous myocardial infarction (n = 18, 20.7%), previous PCI (n = 12, 13.8%), stroke or transient ischemic attack (TIA) (n = 6, 6.9%), and peripheral artery disease (PAD) (n = 14, 16.1%).

In addition, 14 patients (16.1%) had preoperative eGFR below 60 mL/min. Baseline demographic and clinical characteristics are summarized in Table 1.

Postoperative AKI, defined as an increase in serum creatinine of more than 0.3 mg/dL within 48 h, or to more than 1.5 times baseline, occurred in 36 patients (41.4%). In 34 of these patients, AKI was mild and transient, whereas 2 required temporary RRT. No patient required permanent RRT.

Vitamin 25(OH)D3 deficiency was the most common in the study population, accounting for 66 patients (75.9%), while only 21 patients (24.1%) had higher levels. Retinol deficiency was observed in 2 patients; the majority (60.9%, n = 53) had values within the normal range, and 36.8% (n = 32) had values above the normal range. Tocopherol levels were within normal values in 88.5% (n = 77), while 10 patients (11.5%) showed levels that were excessive.

Vitamin concentrations were statistically significantly higher in the AKI subgroup; however, only retinol levels differed significantly between subgroups (p = 0.046) (Table 1). Retinol concentrations correlated positively with preoperative creatinine (Spearman’s rho 0.321, p = 0.002), postoperative day 0 creatinine (Spearman’s rho 0.333, p = 0.002), and postoperative day 1 creatinine (Spearman’s rho 0.268, p = 0.012), and negatively with preoperative eGFR (Spearman’s rho −0.288, p = 0.007). The association with postoperative day 2 creatinine did not reach statistical significance (Spearman’s rho 0.209, p = 0.053) (Figure 2).

Two patients who required temporary RRT had the highest retinol levels compared to those with AKI who did not require RRT and with patients without AKI (p = 0.026, 1.22 (1.05 to 1.38) mcg/mL vs. 0.63 (0.54 to 0.77) mcg/mL vs. 0.56 (0.45 to 0.72) mcg/mL).

3.2. Subdivision into Diabetic and Non-Diabetic Patients

Given that several studies have highlighted the association between diabetic nephropathy and alterations in vitamin concentrations, we analyzed vitamin status in the relevant subgroups. We did not reveal differences between subgroups with and without DM, with or without AKI (Table 2).

3.3. Sex-Stratified Analysis

Male dominance was observed in our study population. Therefore, we performed a sex-stratified analysis to assess whether sex could account for the variance in vitamin concentrations.

In linear regression analysis, sex was significantly associated with preoperative 25(OH)D3 concentrations (unstandardized β = −12.1, (95% CI: −21.4: −2.9), p = 0.011), indicating lower vitamin D in women than in men. Sex alone explained approximately 7% of the variance in 25(OH)D3 concentrations (R2 = 0.074, adjusted R2 = 0.063). Sex was not significantly associated with serum retinol concentrations (unstandardized β = 0.02, 95% CI −0.11 to 0.14, p = 0.759) and had an almost negligible impact on the variance in its concentration (R2 = 0.001, adjusted R2 = −0.011).

Tocopherol concentration was not significantly associated with sex (unstandardized β = −3.0 mcg/mL, 95% CI −6.3 to 0.3, p = 0.077), with sex accounting for only a small proportion of the variance in its concentration (R2 = 0.036, adjusted R2 = 0.025).

4. Discussion

Our study demonstrated that patients who developed cardiac surgery-associated AKI had higher preoperative retinol levels than those without the complication. Moreover, retinol correlated with both preoperative and postoperative creatinine levels, suggesting a close relationship between vitamin A status and renal function. Notably, serum retinol concentrations within the higher reference range may still correlate with AKI, suggesting that even subclinical variation in vitamin A status may be clinically relevant. Tocopherol levels were also high in the AKI group; however, the difference was not statistically significant.

Vitamin A and its metabolites are essential for human health and play important roles in immune function, cell differentiation, adipose tissue and glucose metabolism, bone mineralization, and nocturnal vision [13]. Vitamin A is obtained from dietary sources [19]: beta-carotene from plants and retinyl esters from animal products such as liver, dairy products, and egg yolk. Retinol is converted in the intestinal epithelium to retinyl esters in chylomicrons, which are then stored or metabolized to retinol and its derivatives in the liver.

The retinol-binding protein 4 (RBP4) binds and transports vitamin A to extrahepatic tissues [20].

Kidneys are important organs in maintaining vitamin A homeostasis, as vitamin A bound to serum RBP4 is reabsorbed in 99% in the proximal tubules via endocytic receptor megalin [21,22,23]. An experimental model of megalin deficiency altered vitamin A metabolism by accelerating the mobilization of hepatic vitamin A stores to maintain normal plasma levels [21]. Vitamin A homeostasis is also disturbed in CKD, and patients with impaired kidney function may exhibit elevated circulating retinol, retinoic acid, and RBP4 levels [24].

Frey et al. [25] showed that the occurrence of RBP4 isoforms and their levels are increased in CKD patients, whereas they do not differ between patients with chronic liver disease and healthy controls. This observation may indicate the significance of RBP4 as a marker of kidney function, independent of liver disorders. There are conflicting opinions regarding the relationship between altered vitamin A metabolism and comorbidities such as diabetes and obesity [26]. Abnormal vitamin A and RBP4 levels have been associated with diabetes and insulin resistance, obesity, and dyslipidemia [27].

RBP4 has also been proposed as a novel biomarker for cardiovascular disease due to its association with established cardiovascular risk factors [27,28]. Elevated RBP4 has been linked to major adverse cardiac events in patients with chronic heart failure [29]. The link between vitamin D deficiency and postoperative agitation or other mental status changes after cardiac surgery has been reported [17]. Though retinoid signaling in brain function and mood regulation is important, direct evidence linking perioperative serum retinol levels with postoperative delirium has not yet been demonstrated.

Our findings of a positive correlation between retinol and both preoperative and postoperative creatinine levels are consistent with studies showing higher retinol levels in patients with impaired kidney function. In the CKD subgroup of the National Health and Nutrition Examination Survey (NHANES), serum vitamin A levels were negatively correlated with eGFR (r = −0.56) and positively correlated with creatinine and blood urea nitrogen [30]. Notably, higher serum vitamin A levels were independently associated with all-cause mortality in the CKD population.

Increased retinol levels have been suggested to contribute to immune activation [31], potentially explaining both our results and those of other studies.

Several biomarkers have been investigated for early AKI detection and staging scores. Among the proposed molecules, tissue inhibitor of metalloproteinase 2 (TIMP-2), insulin-like growth factor-binding protein 7 (IGFBP7), kidney injury molecule 1 (KIM-1), and neutrophil gelatinase-associated lipocalin (NGAL) have demonstrated high clinical utility [9,32,33]. Urinary RBP showed similar predictive power as more established serum markers [32,34]. NephroCheck, which combines the TIMP2•IGFBP7 panel, demonstrated promising predictive value in cardiac surgery and transcatheter interventions [35,36]; however, the precise thresholds for different intervention models need to be validated.

In turn, retinoic acid has protective properties, is involved in the repair of renal tubular injury, and promotes podocyte differentiation [21]. It participates in cellular proliferation, differentiation, and apoptosis [37]. Exogenous pharmacological retinoic acid may enhance the treatment of kidney cancer or diabetic kidney disease [38]. Although experimental studies have focused on retinoic acid, the biologically active metabolite of vitamin A with potential nephroprotective properties, our findings relate specifically to circulating retinol. Retinoic acid acts at the cellular level through nuclear receptors and gene-regulatory effects, and its tissue concentrations are tightly controlled and difficult to measure reliably in routine clinical practice.

Though its analysis would be beneficial, we sought to propose markers that would be available in clinical diagnostics.

In particular, identification of markers that are feasible for early recognition of surgery-associated AKI is beneficial for early implementation of therapy [39]. In this context, retinol may possibly represent an additional, readily measurable marker associated with renal vulnerability for AKI occurrence. This hypothesis requires confirmation in larger-scale studies.

Among laboratory data, preoperative renal function parameters, erythrocyte count and hemoglobin differed in patients with postoperative AKI. This likely reflects the influence of baseline renal dysfunction and chronic anemia, as the study group had a high rate of comorbidities, which might have affected the outcome and led to anemia of chronic disease. However, most patients in this study developed only mild postoperative kidney injury, and only two required RRT. The higher proportion of older patients in the AKI subgroup is consistent with previous reports and reflects the age-related decline in renal function [1].

Our findings confirmed previous reports on the existing interaction between retinol and kidney function. The association between higher preoperative retinol concentrations and postoperative AKI may reflect impaired renal handling of retinol-RBP4 complexes rather than a direct causal effect of vitamin A excess. Under physiological conditions, retinol is bound to RBP4 and reabsorbed in the proximal tubules via megalin-mediated endocytosis. Any disturbances in this pathway may lead to altered circulating vitamin A levels. Accordingly, elevated retinol may serve as a marker of early renal vulnerability in patients undergoing cardiac surgery.

This interpretation is consistent with previous studies showing altered vitamin A homeostasis in CKD. However, we should also recognize the pro: and anti-inflammatory properties of alterations in vitamin status. The laboratory research by Gans et al. [40] derived proliferative cardiac cells from the human left ventricle, treated them with retinoic acid, and showed increased secretion of inflammatory factors, immune cell activation, and decreased extracellular matrix expression. The authors underlined the surge in cardiac vitamin A metabolism that occurs after heart injury, such as myocardial infarction, resulting from mobilization of vitamin A from peripheral stores and the concomitant upregulation of enzymes involved in retinol metabolism.

They stated that in heart injury, retinol may contribute to adverse cardiac remodeling. This study is important in the context of our study setting, as cardiac surgery, as an injury, might also impede mechanisms activating retinol metabolism. We should be aware that increased retinol concentrations in our cohort may identify patients with combined cardiorenal vulnerability. Further experimental studies are necessary to assess this hypothesis.

Our study group represents a real-life, all-comers population of patients undergoing cardiac surgery for CAD and AS. In this setting, our findings may serve as a preliminary report that vitamin status could be a useful parameter in the preoperative risk assessment and prehabilitation. This is particularly relevant in cardiac surgery, CAD, and AS patients, who are burdened with a significant rate of comorbidities, including diabetes, arterial hypertension, COPD, diffuse atherosclerosis, and PAD, all of which may affect kidney function. Moreover, the use of pharmacotherapy for heart failure and coronary artery disease, such as angiotensin-converting enzyme inhibitors and sodium-glucose cotransporter 2 (SGLT2) inhibitors, may influence kidney function in the preoperative and perioperative settings.

Currently, there is no targeted therapeutic medication that should be implemented to prevent AKI. Further analyses verifying the medication’s effect on retinol, as well as the uncontrolled use of supplements by patients, are important.

Recent literature has emphasized a patient-centered perspective in cardiac surgery, highlighting both clinical factors, including disease progression and co-morbidities, and psychosocial challenges such as anxiety, depression, and lack of social support as important determinants of postoperative recovery and long-term outcomes [41,42]. In this context, our findings regarding pre-operative kidney function and vitamin status may be interpreted as the need for wide-spectrum prehabilitation, which may improve not only patients’ surgical outcomes and survival, but also quality of life.

Finally, we analyzed vitamin levels in patients with and without diabetes concerning their risk of cardiac surgery-associated AKI. In previous studies, a low 25(OH)3 was associated with a higher risk of AKI and dialysis in the diabetic population [43] or critically ill [44]. The combined effect of CKD and vitamin D deficiency for postsurgical outcomes, including 30-day mortality, AKI, pneumonia, acute myocardial infarction, and atrial arrhythmias, has also been postulated [45]. We did not reveal any significant differences between diabetic and non-diabetic patients in either vitamin D, A, or E.

Moreover, we did not observe a significant association between preoperative vitamin D and tocopherol and AKI. Several factors may account for these findings. It should be noted that the majority of our study group had low vitamin D levels, similarly to the general Polish population [46,47]. This issue may affect how we interpret our results and hinder our ability to identify a concentration-related relationship with AKI. Interesting findings come from the meta-analysis by Zhang et al. [48], which suggested that the serum 1,25(OH) vitamin levels, rather than 25(OH) vitamin D, are significantly lower in AKI patients.

Thus, more detailed vitamin D subtype analysis [49] may be necessary in these patient groups. Moreover, only mild, mostly transient stages of cardiac surgery-associated AKI predominated in our study, with just two patients requiring temporary renal replacement therapy, which may have reduced the contrast between both groups. Third, our study group was relatively small, so we may have missed weaker associations for vitamins D and E compared with the more robust signal observed for retinol.

While vitamin D levels are more clearly defined in the Polish population and are more commonly examined in daily practice, retinol levels are rarely evaluated. In the study by Godala et al. [50], the mean retinol concentration in the healthy population was 1.8 μmol/L (approx. 0.52 µg/mL) and was even lower in patients with metabolic syndrome (1.37 μmol/L). Similar or only slightly higher values were presented in the analysis of healthy subjects from five European countries [51].

Therefore, our AKI group presents higher values. In our cohort, the median retinol concentration was 0.64 mcg/mL, and the mean retinol concentration in patients with AKI was 0.7 mcg/mL, which is the upper reference limit for high retinol levels. In non-AKI patients, the median was 0.56 mcg/mL, and the mean was 0.59 mcg/mL. Therefore, retinol concentrations in the AKI group were at the upper end of, or above, the reference range.

Consistent with previous surgical series [52,53,54], our cohort showed a male predominance among patients undergoing coronary artery and valvular surgical procedures. This observation likely reflects the earlier onset of coronary artery disease and degenerative aortic stenosis in men of operative age, and delays in operative interventions in females due to the fact that women often present later and are referred for surgery at an older age with a higher risk profile [55].

These factors are also related to the prevalence of AKI [56]. A meta-analysis [57] of 64 studies showed that females are more prone to develop AKI than males. However, further analysis indicated a strong dependence on the higher age and co-morbidities of females at the time of surgery for AKI occurrence. According to Demirjian et al. [58], the definition of pre-operative kidney function and misclassification due to AKI, as defined by absolute change in creatinine, may lead to misleading outcomes evaluation.

Moreover, in sex-stratified analyses, we observed a statistically significant difference in preoperative 25(OH)D3 concentrations, with women having lower vitamin D than men, and sex explained only 7% of the variance in 25(OH)D3. In contrast, sex was not significantly associated with serum retinol concentrations and showed only a small, non-significant trend towards lower tocopherol levels in women, with sex accounting for 4% of the variance in vitamin E. Overall, these findings suggest that, in our study group, sex had a trivial to modest influence on vitamin status, and other factors are probably more likely to determine their concentrations.

4.1. Future Perspective

In the context of the emerging “twin transformation” in cardiothoracic surgery, which combines digital innovation with sustainability-oriented care models [59], improved risk stratification for cardiac surgery-associated AKI using clinical variables and biomarkers may contribute to more precise and clinically efficient perioperative pathways. A recent study by Pylarinou et al. [60] introduced a clinical decision support system specifically designed for post-surgical cardiovascular remote monitoring, integrating patient history, intraoperative data, monitoring streams, and surgical outcomes into an artificial intelligence-based architecture that may guide clinical recommendations.

The implementation of artificial intelligence-assisted decision-making tools, the earlier identification of patients at higher risk of post-operative complications, including even a mild degree of AKI, and targeted modifications to improve outcomes by reducing the complication rate, the need for RRT, and prolonged intensive care stay.

4.2. Limitations

This study has several limitations. Firstly, in our study, serum or urine RBP4 was not measured, which limited the assessment of vitamin A transport and metabolism. Secondly, the study population was burdened by several comorbidities, which may limit generalizability. Finally, given that the patient group was relatively small, particularly with respect to severe AKI and RRT use, and the borderline statistical significance for retinol (p = 0.046), and the exploratory nature of the study, the present finding should be treated as hypothesis-generating.

5. Conclusions

Retinol may be associated with increased vulnerability to cardiac surgery-associated AKI. However, its clinical utility as a biomarker requires validation in larger cohorts.

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Supplementary Materials

The following supporting information can be downloaded at https://www.mdpi.com/article/10.3390/nu18121921/s1.

Supplement file at the original source: open the original paper. This file is not included in this text import.

Author Contributions

Conceptualization, A.O.-W., E.S.-C. and T.U.; methodology, E.S.-C. and M.K.-Ł.; formal analysis, A.O.-W., E.S.-C., T.U., M.K.-Ł., A.S. and J.K.; investigation, A.O.-W., E.S.-C., T.U., M.K.-Ł., A.S. and J.K.; resources, A.O.-W., E.S.-C. and M.K.-Ł.; data curation, A.O.-W. and E.S.-C.; writing: original draft preparation, A.O.-W., E.S.-C. and T.U.; writing: review and editing M.K.-Ł., J.K., A.S., B.P., M.J. and A.D.; supervision, A.D. and M.J.; project administration, A.O.-W. and E.S.-C.; funding acquisition, A.O.-W. and M.J. All authors have read and agreed to the published version of the manuscript.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki and approved by the Bioethics Committee of the Poznan University of Medical Sciences, Poznan, Poland (No 151/25, dated 3 April 2025).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The original contributions presented in this study are included in the article/Supplementary Material. Further inquiries can be directed to the corresponding author.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript: AKIacute kidney injuryAFatrial fibrillationALATalanine aminotransferaseASaortic stenosisAspATaspartate aminotransferaseAVRaortic valve replacementBMIbody mass indexCABGcoronary artery bypass graftingCADcoronary artery diseaseCKDchronic kidney diseaseCOPDchronic obstructive pulmonary diseaseCPBcardiopulmonary bypassDMdiabetes mellituseGFRestimated glomerular filtration rateIGTimpaired glucose toleranceHAarterial hypertensionHFheart failureMImyocardial infarctionMDRDModification of Diet in Renal DiseaseNTproBNPN-terminal pro-B-type natriuretic peptidePADperipheral arterial diseasePCIpercutaneous coronary interventionRRTrenal replacement therapyTIAtransient ischemic attack

References

1. Scurt F.G. Bose K. Mertens P.R. Chatzikyrkou C. Herzog C. Cardiac Surgery: Associated Acute Kidney Injury Kidney360 2024 5 909 926 10.34067/KID.0000000000000466 38689404 PMC11219121
2. Sun C. Chen D. Jin X. Xu G. Tang C. Guo X. Tang Z. Bao Y. Wang F. Shen R. Association between acute kidney injury and prognoses of cardiac surgery patients: Analysis of the MIMIC-III database Front. Surg. 2023 9 1044937 10.3389/fsurg.2022.1044937 36684234 PMC9853392
3. Wang Y. Bellomo R. Cardiac surgery-associated acute kidney injury: Risk factors, pathophysiology and treatment Nat. Rev. Nephrol. 2017 13 697 711 10.1038/nrneph.2017.119 28869251
4. Kamla C.-E. Meersch-Dini M. Palma L.M.P. Kidney Injury Following Cardiac Surgery: A Review of Our Current Understanding Am. J. Cardiovasc. Drugs 2025 25 337 348 10.1007/s40256-024-00715-8 39799538 PMC12014718
5. Xu Q. Chen G. Ai S. Zheng K. Zhao B. Li X. Acute Kidney Injury in Different Anticoagulation Strategies: A Large-Scale Pharmacoepidemiologic Study Using Real-World Data Cardiovasc. Drugs Ther. 2025 39 563 572 10.1007/s10557-024-07558-0 38319470
6. Haase M. Bellomo R. Haase-Fielitz A. Novel biomarkers, oxidative stress, and the role of labile iron toxicity in cardiopulmonary bypass-associated acute kidney injury J. Am. Coll. Cardiol. 2010 55 2024 2033 10.1016/j.jacc.2009.12.046 20447525
7. Guan C. Li C. Xu L. Zhen L. Zhang Y. Zhao L. Zhou B. Che L. Wang Y. Xu Y. Risk factors of cardiac surgery-associated acute kidney injury: Development and validation of a perioperative predictive nomogram J. Nephrol. 2019 32 937 945 10.1007/s40620-019-00624-z 31243735
8. Liu C.-C. Liu P.-H. Chen H.-T. Chen J.-Y. Lee C.-W. Cheng W.-J. Chen J.-Y. Hung K.-C. Association of Preoperative Prognostic Nutritional Index with Risk of Postoperative Acute Kidney Injury: A Meta-Analysis of Observational Studies Nutrients 2023 15 2929 10.3390/nu15132929 37447255 PMC10346508
9. Hertzberg D. Sartipy U. Lund L.H. Rydén L. Pickering J.W. Holzmann M.J. Heart failure and the risk of acute kidney injury in relation to ejection fraction in patients undergoing coronary artery bypass grafting Int. J. Cardiol. 2019 274 66 70 10.1016/j.ijcard.2018.09.092 30297189
10. Oosterom-Eijmael M. Hermanns H. Lankadeva Y. Hulst A. Cardiac surgery-associated acute kidney injury BJA Educ. 2026 26 92 100 10.1016/j.bjae.2025.11.001 41626591 PMC12853332
11. Shroff G.R. Carlson M.D. Mathew R.O. Coronary Artery Disease in Chronic Kidney Disease: Need for a Heart: Kidney Team-Based Approach Eur. Cardiol. Rev. 2021 16 e48 10.15420/ecr.2021.30 PMC8674634 34950244
12. Zhou C. Ye Z. Yang S. Gan X. Zhang Y. Liu M. He P. Zhang Y. Wu Q. Nie J. Associations between Serum 25-hydroxyvitamin D, Sun Exposure Time, Dietary Vitamin D Intake, and New-Onset Acute Kidney Injury among 413,169 UK Adults J. Nutr. 2023 153 713 722 10.1016/j.tjnut.2023.01.006 36931750
13. Rojo-Trejo M.H. Robles-Osorio M.L. Sabath E. Liposoluble vitamins A and E in kidney disease World J. Nephrol. 2022 11 96 104 10.5527/wjn.v11.i3.96 35733655 PMC9160709
14. Krajewska M. Witkowska-Sędek E. Rumińska M. Stelmaszczyk-Emmel A. Sobol M. Majcher A. Pyrżak B. Vitamin D Effects on Selected Anti-Inflammatory and Pro-Inflammatory Markers of Obesity-Related Chronic Inflammation Front. Endocrinol. 2022 13 920340 10.3389/fendo.2022.920340 35769088 PMC9235399
15. Kowalówka M. Górna I. Karaźniewicz-Łada M. Kusyk D. Przysławski J. Drzymała-Czyż S. Nutri-Epigenetic Regulation of Vitamin D: Impact on Metabolism and Biological Functions: Narrative Review Metabolites 2025 15 436 10.3390/metabo15070436 40710536 PMC12299634
16. Varzideh F. Mone P. Kansakar U. Santulli G. Vitamin D in Cardiovascular Medicine: From Molecular Mechanisms to Clinical Translation Nutrients 2026 18 499 10.3390/nu18030499 41683321 PMC12899724
17. Velayati A. Vahdat Shariatpanahi M. Dehghan S. Zayeri F. Vahdat Shariatpanahi Z. Vitamin D and Postoperative Delirium After Coronary Artery Bypass Grafting: A Prospective Cohort Study J. Cardiothorac. Vasc. Anesth. 2020 34 1774 1779 10.1053/j.jvca.2020.02.008 32156511
18. Englberger L. Suri R.M. Li Z. Casey E.T. Daly R.C. A Dearani J. Schaff H.V. Clinical accuracy of RIFLE and Acute Kidney Injury Network (AKIN) criteria for acute kidney injury in patients undergoing cardiac surgery Crit. Care 2011 15 R16 10.1186/cc9960 21232094 PMC3222049
19. Goldman D.M. Warbeck C.B. Barbaro R. Khambatta C. Nagra M. Assessing the Roles of Retinol, Vitamin K2, Carnitine, and Creatine in Plant-Based Diets: A Narrative Review of Nutritional Adequacy and Health Implications Nutrients 2025 17 525 10.3390/nu17030525 39940383 PMC11820685
20. Napoli J.L. Retinoic Acid: The Autacoid for All Seasons Nutrients 2022 14 4526 10.3390/nu14214526 36364786 PMC9654713
21. DiKun K.M. Gudas L.J. Vitamin A and retinoid signaling in the kidneys Pharmacol. Ther. 2023 248 108481 10.1016/j.pharmthera.2023.108481 37331524 PMC10528136
22. Raila J. Willnow T.E. Schweigert F.J. Megalin-mediated reuptake of retinol in the kidneys of mice is essential for vitamin A homeostasis J. Nutr. 2005 135 2512 2516 10.1093/jn/135.11.2512 16251603
23. Nielsen R. Christensen E.I. Birn H. Megalin and cubilin in proximal tubule protein reabsorption: From experimental models to human disease Kidney Int. 2016 89 58 67 10.1016/j.kint.2015.11.007 26759048
24. Jing J. Isoherranen N. Robinson-Cohen C. Petrie I. Kestenbaum B. Yeung C. Chronic Kidney Disease Alters Vitamin A Homeostasis via Effects on Hepatic RBP4 Protein Expression and Metabolic Enzymes Clin. Transl. Sci. 2016 9 207 215 10.1111/cts.12402 27277845 PMC5351338
25. Frey S.K. Nagl B. Henze A. Raila J. Schlosser B. Berg T. Tepel M. Zidek W. Weickert M.O. Pfeiffer A.F. Isoforms of retinol binding protein 4 (RBP4) are increased in chronic diseases of the kidney but not of the liver Lipids Health Dis. 2008 7 29 10.1186/1476-511X-7-29 18752671 PMC2533662
26. Frey S.K. Vogel S. Vitamin A metabolism and adipose tissue biology Nutrients 2011 3 27 39 10.3390/nu3010027 22254074 PMC3257733
27. Rychter A.M. Skrzypczak-Zielińska M. Zielińska A. Eder P. Souto E.B. Zawada A. Ratajczak A.E. Dobrowolska A. Krela-Kaźmierczak I. Is the Retinol-Binding Protein 4 a Possible Risk Factor for Cardiovascular Diseases in Obesity? Int. J. Mol. Sci. 2020 21 5229 10.3390/ijms21155229 32718041 PMC7432399
28. Alkharfy K.M. Al-Daghri N.M. Vanhoutte P.M. Krishnaswamy S. Xu A. Serum retinol-binding protein 4 as a marker for cardiovascular disease in women PLoS ONE 2012 7 e48612 10.1371/journal.pone.0048612 23119072 PMC3485358
29. Li X.Z. Zhang K.Z. Yan J.J. Wang L. Wang Y. Shen X.Y. Sun H.X. Liu L. Zhao C. He H.W. Serum retinol-binding protein 4 as a predictor of cardiovascular events in elderly patients with chronic heart failure ESC Hearth Fail. 2020 7 542 550 10.1002/ehf2.12591 PMC7160478 31965727
30. Feng Y. Li Y. Chen S. Hu N. Liao D. Vitamin A is associated with all-cause mortality in patients with chronic kidney disease: A population-based cohort study Front. Nutr. 2024 11 1469844 10.3389/fnut.2024.1469844 39698241 PMC11652194
31. Shi L. Belbellaj W. Manousaki D. Association of Vitamins and Minerals with Type 1 Diabetes Risk: A Mendelian Randomization Study Nutrients 2025 17 3297 10.3390/nu17203297 41156550 PMC12566610
32. Parikh C.R. Coca S.G. Thiessen-Philbrook H. Shlipak M.G. Koyner J.L. Wang Z. Edelstein C.L. Devarajan P. Patel U.D. Zappitelli M. Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery J. Am. Soc. Nephrol. 2011 22 1748 1757 10.1681/ASN.2010121302 21836143 PMC3171945
33. Che M. Xie B. Xue S. Dai H. Qian J. Ni Z. Axelsson J. Yan Y. Clinical usefulness of novel biomarkers for the detection of acute kidney injury following elective cardiac surgery Nephron Clin. Pract. 2010 115 c66 c72 10.1159/000286352 20173352
34. Ratajczyk K. Konieczny A. Czekaj A. Piotrów P. Fiutowski M. Krakowska K. Kowal P. Witkiewicz W. Marek-Bukowiec K. The Clinical Significance of Urinary Retinol-Binding Protein 4: A Review Int. J. Environ. Res. Public Health 2022 19 9878 10.3390/ijerph19169878 36011513 PMC9408023
35. Monaco F. Labanca R. Fresilli S. Barucco G. Licheri M. Frau G. Osenberg P. Belletti A. Effect of Urine Output on the Predictive Precision of NephroCheck in On-Pump Cardiac Surgery With Crystalloid Cardioplegia: Insights from the PrevAKI Study J. Cardiothorac. Vasc. Anesth. 2024 38 1689 1698 10.1053/j.jvca.2024.04.029 38862287
36. Dusse F. Edayadiyil-Dudásova M. Thielmann M. Wendt D. Kahlert P. Demircioglu E. Jakob H. Schaefer S.T. Pilarczyk K. Early prediction of acute kidney injury after transapical and transaortic aortic valve implantation with urinary G1 cell cycle arrest biomarkers BMC Anesthesiol. 2016 16 76 10.1186/s12871-016-0244-8 27609347 PMC5016985
37. Liu Y. Sun D. Huang Y. Shen Y. Chen T. Chen W. Zhu L. Wang F. Hong G. Luo Y. Bibliometric analysis of research on retinoic acid in the field of kidney disorders Front. Pharmacol. 2024 15 1435889 10.3389/fphar.2024.1435889 39211779 PMC11357955
38. Lavudi K. Nuguri S.M. Olverson Z. Dhanabalan A.K. Patnaik S. Kokkanti R.R. Targeting the retinoic acid signaling pathway as a modern precision therapy against cancers Front. Cell Dev. Biol. 2023 11 1254612 10.3389/fcell.2023.1254612 37645246 PMC10461636
39. Moriyama T. Hagihara S. Shiramomo T. Nagaoka M. Iwakawa S. Kanmura Y. Comparison of three early biomarkers for acute kidney injury after cardiac surgery under cardiopulmonary bypass J. Intensive Care 2016 4 41 10.1186/s40560-016-0164-1 27330813 PMC4915135
40. Gans I.M. Lessard A.J. Ryzhov S.V. Vary C.P. Sawyer D.B. Retinoic acid promotes expression of inflammatory factors in proliferative adult human heart cells Am. J. Physiol. Cell Physiol. 2026 330 C367 C378 10.1152/ajpcell.00696.2025 41412446 PMC12990825
41. Leivaditis V. Sepetis A. Mulita F. Mitsos S. Baikoussis N.G. Koletsis E. Assimakopoulos S.F. Maniatopoulos A.A. Liolis E. Nikolakopoulos K. Patient-Centered Cardiac Surgery: Psychosocial Challenges, Evidence-Based Interventions, and Future Horizons Healthcare 2025 13 2957 10.3390/healthcare13222957 41302346 PMC12652157
42. Shuker B. Essak K. Patteril M. Prehabilitation and enhanced recovery after cardiac surgery Best Pract. Res. Clin. Anaesthesiol. 2025 39 157 165 10.1016/j.bpa.2025.08.002 42219876
43. Li X.-H. Luo Y.-Z. Mo M.-Q. Gao T.-Y. Yang Z.-H. Pan L. Vitamin D deficiency may increase the risk of acute kidney injury in patients with diabetes and predict a poorer outcome in patients with acute kidney injury BMC Nephrol. 2024 25 333 10.1186/s12882-024-03781-x 39375595 PMC11460229
44. Braun A.B. Litonjua A.A. Moromizato T. Gibbons F.K. Giovannucci E. Christopher K.B. Association of low serum 25-hydroxyvitamin D levels and acute kidney injury in the critically ill* Crit. Care Med. 2012 40 3170 3179 10.1097/CCM.0b013e318260c928 22975885
45. Hung K.-C. Yu T.-S. Hung I.-Y. Wu J.-Y. Yew M. Chen I.-W. Impact of vitamin D deficiency on postoperative outcomes in patients with chronic kidney disease undergoing surgery: A retrospective study Sci. Rep. 2025 15 9757 10.1038/s41598-025-93807-7 40118908 PMC11928554
46. Główka A.K. Kowalówka M. Burchardt P. Komosa A. Kruszyna Ł. Andrusiewicz M. Przysławski J. Karaźniewicz-Łada M. Selected Psychosocial Factors, Nutritional Behavior, and the Analysis of Concentrations of Selected Vitamins in Patients with Cardiovascular Diseases Nutrients 2024 16 1866 10.3390/nu16121866 38931221 PMC11206887
47. Abouzid M. Kruszyna Ł. Kerner J. Kagan L. Mikulska-Sauermann A. Filipowicz D. Resztak M. Główka F.K. Karaźniewicz-Łada M. Exploration of vitamin D hydroxy metabolites C3 epimers in patients with cardiovascular disease: An observational study Biosci. Rep. 2025 45 BSR20241558 10.1042/BSR20241558 39873593 PMC12188998
48. Zhang H. Jiang Y. Shi N. Lu Y.-Q. Serum vitamin D levels and acute kidney injury: A systemic review and meta-analysis Sci. Rep. 2022 12 20365 10.1038/s41598-022-24560-4 36437252 PMC9701671
49. Abouzid M. Kerner J. Mikulska-Sauermann A. Filipowicz D. Resztak M. Główka F. Kagan L. Karaźniewicz-Łada M. Extension of an Ultra-High Performance Liquid Chromatography: MS/MS Method for the Determination of C3 Epimers of 25-Hydroxyl Derivatives of Vitamin D in Human Plasma J. Chromatogr. Sci. 2025 63 bmaf031 10.1093/chromsci/bmaf031 40444740 PMC12123413
50. Godala M.M. Materek-Kuśmierkiewicz I. Moczulski D. Rutkowski M. Szatko F. Gaszyńska E. Tokarski S. Kowalski J. Lower Plasma Levels of Antioxidant Vitamins in Patients with Metabolic Syndrome: A Case Control Study Adv. Clin. Exp. Med. 2016 25 689 700 10.17219/acem/41049 27629843
51. Olmedilla B. Granado F. Southon S. Wright A.J.A. Blanco I. Gil-Martinez E. Berg H.v.D. Corridan B. Roussel A.-M. Chopra M. Serum concentrations of carotenoids and vitamins A, E, and C in control subjects from five European countries Br. J. Nutr. 2001 85 227 238 10.1079/BJN2000248 11242491
52. Hirnle G. Stankiewicz A. Mitrosz M. Aboul-Hassan S.S. Deja M. Rogowski J. Cichoń R. Anisimowicz L. Bugajski P. Tobota Z. Gender Differences in Survival after Coronary Artery Bypass Grafting: 13-Year Results from KROK Registry J. Clin. Med. 2024 13 4080 10.3390/jcm13144080 39064120 PMC11277894
53. Krey R. Jakob M. Karck M. Arif R. Farag M. Male: female differences following concomitant coronary artery bypass grafting and aortic valve replacement surgery ESC Heart Fail. 2024 11 2913 2923 10.1002/ehf2.14847 38797557 PMC11424324
54. Urbanowicz T. Michalak M. Olasińska-Wiśniewska A. Haneya A. Straburzyńska-Migaj E. Bociański M. Jemielity M. Gender differences in coronary artery diameters and survival results after off-pump coronary artery bypass (OPCAB) procedures J. Thorac. Dis. 2021 13 2867 2873 10.21037/jtd-20-3356 34164178 PMC8182499
55. Rizvanovic S. Arnreiter M. Florian A. Sandner S. Coronary artery surgery outcome differences by sex Indian J. Thorac. Cardiovasc. Surg. 2026 42 31 40 10.1007/s12055-025-01958-z 41438524 PMC12719376
56. Oosterom-Eijmael M.J.P. van Eeghen S.A. Lankadeva Y.R. Hermanides J. Hulst A.H. van Raalte D.H. Do Sex Differences Matter in Cardiac Surgery-Associated Acute Kidney Injury?: A Narrative Review J. Intensive Care Med. 2025 8850666251364783 10.1177/08850666251364783 40767251
57. Neugarten J. Sandilya S. Singh B. Golestaneh L. Sex and the Risk of AKI Following Cardio-thoracic Surgery: A Meta-Analysis Clin. J. Am. Soc. Nephrol. 2016 11 2113 2122 10.2215/CJN.03340316 27797892 PMC5142065
58. Demirjian S. Huml A. Bakaeen F. Poggio E. Geube M. Shaw A. Gillinov A.M. Gadegbeku C.A. Sex bias in prediction and diagnosis of cardiac surgery associated acute kidney injury BMC Nephrol. 2024 25 180 10.1186/s12882-024-03614-x 38778259 PMC11112848
59. Leivaditis V. Gottardi R. Maniatopoulos A.A. Mulita F. Pylarinou C. Papadoulas S. Nikolakopoulos K. Panagiotopoulos I. Koletsis E. Dahm M. Twin Transformation in Cardiothoracic Surgery: The Convergence of Digital Innovation and Sustainability J. Cardiovasc. Dev. Dis. 2026 13 122 10.3390/jcdd13030122 41892711 PMC13026314
60. Pylarinou C. Mulita F. Koletsis E. Leivaditis V. Liolis E. Gortzis L. Mavrilas D. A Clinical Decision Support System for Post-Surgical Cardiovascular Remote Monitoring Clin. Pract. 2026 16 93 10.3390/clinpract16050093 42187527 PMC13204805
Figure 1

Study flowchart.

Figure image at the original source: open the original paper. This file is not included in this text import.
Figure 2

Correlations between vitamins and perioperative creatinine levels. * p < 0.05, ** p < 0.01, *** p < 0.001. Blue colors correspond to positive correlation coefficients, red colors correspond to negative correlation coefficients. The saturation of colors reflects the absolute value of the correlation coefficient.

Figure image at the original source: open the original paper. This file is not included in this text import.
Table 1

Baseline demographic and clinical characteristics.

All Patients
(n = 87)
Patients with AKI (n = 36)Patients Without AKI (n = 51) p
Age66 (61.5 to 71)68.5 (64 to 73)66 (60 to 70)0.025
Male sex (n, %)72 (82.8)29 (80.6)43 (84.3)0.78
BMI (kg/m2, median, Q1: Q3)28.4 (25.6 to 31.4)28.6 (26.2 to 31.1)28.3 (24.9 to 32.2)0.73
HA (n, %)73 (83.9)31 (86.1)42 (82.4)0.77
DM/IGT (n, %)32 (36.8)16 (44.4)16 (31.4)0.21
Only DM (n, %)28 (32.2)15 (41.7)13 (25.5)0.11
AF (n, %)10 (11.5)4 (11.1)6 (11.8)1.00
COPD/asthma (n, %)7 (8.1)2 (5.6)5 (9.8)0.70
History of MI (n, %)18 (20.9)6 (16.7)12 (24)0.59
History of PCI (n, %)12 (14.0)5 (13.9)7 (14)1.00
Previous stroke or TIA (n, %)36 (6.0)2 (5.6)4 (8.0)1.00
PAD (n, %)14 (16.3)8 (22.2)6 (12.0)0.24
CPB (n, %)25 (28.7)8 (22.2)17 (33.3)0.34
Preoperative creatinine (umol/L, median, Q1: Q3)0.90 (0.76 to 1.02)0.95 (0.82 to 1.15)0.87 (0.73 to 0.98)0.01
Preoperative eGFR (mL/min, median, Q1: Q3)85.2 (68.1 to 99.1)68.5 (59.3 to 89.4)87.8 (74.4 to 103.2)0.002
Preoperative eGFR < 60 mL/min (n, %)14 (16.1)11 (30.6)3 (5.9)0.002
Preoperative leucocyte count (×109/L, median, Q1: Q3)7.4 (6 to 8.6)7.5 (6.3 to 8.3)7.1 (5.8 to 8.8)0.97
Preoperative haemoglobin (mmol/L, median, Q1: Q3)8.6 (8.2 to 9.3)8.4 (8.1 to 9.1)8.8 (8.4 to 9.5)0.035
Preoperative erythrocyte count (×1012/L, median, Q1: Q3)4.7 (4.4 to 5.0)4.6 (4.3 to 4.8)4.8 (4.5 to 5.1)0.04
Preoperative platelet count (×109/L, median, Q1: Q3)230 (193 to 269)228 (188 to 253)230 (197 to 292)0.26
Preoperative NTproBNP (pg/mL, median, Q1: Q3)427.7 (184.1 to 570.1)462.6 (435.5 to 605.9)186.9 (106.9 to 432.3)0.19
ALT (U/L, median, Q1: Q3)33.0 (21.0 to 44.3)33.5 (23.3 to 41.3)32.0 (21.0 to 47.3)0.84
AST (U/L, median, Q1: Q3)27.0 (22.8 to 37.0)28.0 (24.3 to 40.5027 (22.0 to 34.8)0.41
Postoperative 0 day
Creatinine (umol/L, median, Q1: Q3)
1.04 (0.92 to 1.22)1.23 (1.03 to 1.42)0.93 (0.84 to 1.07)<0.001
Postoperative 1 day
Creatinine (umol/L, median, Q1: Q3)
1.12 (0.88 to 1.39)1.43 (1.22 to 1.75)0.93 (0.80 to 1.11)<0.001
Postoperative 2 day
Creatinine (umol/L, median, Q1: Q3)
0.98 (0.78 to 1.27)1.26 (1.09 to 1.59)0.84 (0.68 to 1.00)<0.001
Retinol (mcg/mL, median, Q1: Q3)0.59 (0.48 to 0.75)0.64 (0.56 to 0.83)0.56 (0.45 to 0.72)0.046
25(OH)D3 (ng/mL, median, Q1: Q3)14.4 (6.1 to 27.2)15.0 (7.6 to 28.2)10.2 (5.7 to 25.2)0.37
Tocopherol (mcg/mL, median, Q1: Q3)12.7 (9.7 to 16.5)13.4 (9.6 to 16.9)12.5 (9.9 to 15.7)0.33

Abbreviations: AKI: acute kidney injury; AF: atrial fibrillation; ALT: alanine aminotransferase; AST: aspartate aminotransferase; BMI: body mass index; COPD: chronic obstructive pulmonary disease; CPB: cardiopulmonary bypass; DM: diabetes mellitus; eGFR: estimated glomerular filtration rate; IGT: impaired glucose tolerance; HA: arterial hypertension; MI: myocardial infarction; NTproBNP: N-terminal pro-B-type natriuretic peptide; PAD: peripheral arterial disease; PCI: percutaneous coronary intervention; TIA: transient ischemic attack.

Table 2

Vitamin levels in patients with and without DM, presenting with or without AKI.

DM(+)AKI(+)DM(+)AKI(−)DM(−)AKI(+)DM(−)AKI(−) p
Retinol (mcg/mL, median, Q1: Q3)0.69 (0.57 to 0.87)0.56 (0.46 to 0.76)0.63 (0.54 to 0.73)0.56 (0.45 to 0.71)0.20
25(OH)D3 (ng/mL, median, Q1: Q3)14.7 (5.6 to 24.0)9.9 (6.2 to 18.1)17.0 (9.0 to 31.1)11.5 (5.6 to 32.3)0.41
Tocopherol (mcg/mL, median, Q1: Q3)12.8 (9.4 to 16.8)13.9 (13.0 to 17.8)13.9 (11.1 to 16.9)11.3 (9.6 to 15.0)0.23

Abbreviations: AKI: acute kidney injury; DM: diabetes mellitus. (+) presence; (−) absence.

Publication and source details

Original title: Increased Retinol Levels in Patients with Cardiac Surgery-Associated Acute Kidney Injury: A Prospective Single-Center Exploratory Study

Anna Olasińska-Wiśniewska; Ewelina Swora-Cwynar; Tomasz Urbanowicz; Marta Karaźniewicz-Łada; Julia Kerner; Anna Siemiątkowska; Agnieszka Dobrowolska; Bartłomiej Perek; Marek Jemielity

Nutrients · 2026

* Correspondence: annaolasinska@ump.edu.pl© 2026 by the authors.2026https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.This research received no external funding.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T23:38:17.163563+00:00

DOI: 10.3390/nu18121921 · PMC13304596